Autologous Hematopoietic Stem Cell Transplantation(Universitätsklinikum Hamburg-Eppendorf)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameAutologous Hematopoietic Stem Cell Transplantation(Universitätsklinikum Hamburg-Eppendorf)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversitätsklinikum Hamburg-Eppendorf

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversitätsklinikum Hamburg-Eppendorf

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN/A